(Q38215653)

31 August 2017

1 reference

title

Multiple phenotypic consequences of the Ig/Myc translocation in B-cell-derived tumors (English)

1 reference

31 August 2017

Klein G

1

1 reference

31 August 2017

language of work or name

1 reference

1 September 1989

1 reference

Genes, Chromosomes and Cancer

31 August 2017

published in

1 reference

31 August 2017

volume

1

1 reference

31 August 2017

issue

1

1 reference

31 August 2017

page(s)

3-8

1 reference

Molecular characterization of novel reciprocal translocation t(6;14) in an Epstein-Barr virus-transformed B cell precursor

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

6;7 chromosomal translocation in spontaneously arising rat immunocytomas: evidence for c-myc breakpoint clustering and correlation between isotypic expression and the c-myc target

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Regulation of genome rearrangement events during lymphocyte differentiation

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Combined treatment with interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha up-regulates the expression of HLA class I determinants in Burkitt lymphoma lines.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Elevated c-myc expression facilitates the replication of SV40 DNA in human lymphoma cells

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Expression of a transfected human c-myconcogene inhibits differentiation of a mouse erythroleukaemia cell line

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Expression of B-cell-specific markers in different Burkitt lymphoma subgroups.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Epstein-Barr virus transforms precursor B cells even before immunoglobulin gene rearrangements

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Myc/Ig juxtaposition by chromosomal translocations: some new insights, puzzles and paradoxes

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Phorbol ester-induced terminal differentiation is inhibited in human U-937 monoblastic cells expressing a v-myc oncogene

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Allele-specific down-regulation of MHC class I antigens in Burkitt lymphoma lines.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Avian v-myc replaces chromosomal translocation in murine plasmacytomagenesis.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Endemic Burkitt's lymphoma: phenotypic analysis of tumor biopsy cells and of derived tumor cell lines

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Paired epstein-barr virus-carrying lymphoma and lymphoblastoid cell lines Burkitt's lymphoma patients: Comparative sensitivity to non-specific and to allo-specific cytotoxic responsesin vitro

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Immunophenotypic characterization of follicle-center-cell-derived non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Reversion of tumorigenicity and decreased agarose clonability after EBV conversion of an igh/myc translocation-carrying be line

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Differential expression of HLA antigens on human B-cell lines of normal and malignant origin: a consequence of immune surveillance or a phenotypic vestige of the progenitor cells?

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870010103

7 January 2021

Identifiers

DOI

10.1002/GCC.2870010103

1 reference

31 August 2017

1 reference